Candeira M, Schuch W, Greiner L, Buckley L, Gold H, Langer A, McKane B, Melin M, Oakley M, Schellenbach J, Schuch A, Thiadens SR, Thompson G, Upstill C. "American Cancer Society Lymphedema Workshop: Workgroup V: Collaboration and advocacy.” Cancer 1998; 83(12 Suppl American):2888-90.

Mukamel DB, Gold HT, and Bennett NM. “Cost utility of public clinics to increase pneumococcal vaccines in the elderly,” American Journal of Preventive Medicine 2001; 21(1): 29-34.

Callahan MA, Christos PJ, Gold HT, Mushlin AI, and Daly JM. “Influence of surgical subspecialty training on in-hospital mortality for gastrectomy and colectomy patients.” Annals of Surgery 2003; 238(4):629-36.

Schackman BR, Gold HT, Stone PW, Neumann PJ. “How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?” PharmacoEconomics 2004; 22(5): 293-300.

Gold HT and Dick AW. “Variations in treatment for ductal carcinoma in situ in elderly women.” Medical Care 2004; 42(3): 267-275.

Gold HT and Dick AW. “Re: Trends in the treatment of ductal carcinoma in situ of the breast.” Journal of the National Cancer Institute 2004; 96(11):887-888 (letter).

Korst R, Gold H, Port J, Lee P, Altorki N. “Surveillance CT scans following complete resection for non-small cell lung cancer: analysis of results and costs.” The Journal of Thoracic and Cardiovascular Surgery 2005;129(3):652-60.

Sharma G, Gold HT, Chervenak FA, McCullough L, Alt A, Chasen ST. “Patient preferences regarding first trimester aneuploidy screening.” American Journal of Obstetrics and Gynecology 2005;193(4):1429-36.

Kelley AS, Gold HT, Roach KW, Fins JJ. “Differential medical and surgical house staff involvement in end-of-life decisions: a retrospective chart review.” Journal of Pain and Symptom Management 2006;32(2): 110-117.

Gold HT, Do HT. “Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.” Health Services Research 2007. 42(5):2056-69.

Gold HT. “Caring and Compromise.” Health Affairs 2008; 27(4): 1196 (letter).

Gold HT, Hall MJ, Blinder V, Schackman BR. “Pharmacogenetic testing for UGT1A1 prior to irinotecan administration for metastatic colorectal cancer: a cost-utility analysis.” Medical Decision Making 2007.

Gold HT, Buist D, Field T, Wei FF, Silliman R. “Radiotherapy Delay in Older Women with Early Stage Breast Cancer.” Clinical Medicine and Research 2008.

Gold HT, Do HT, Dick AW. “Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer.” Cancer 2008; 113(11): 3108-3115.

Griggs JJ, Sorbero MS, Ahrendt GM, Stark A, Heininger S, Gold HT, Schiffhauer LM, Dick AW. “The pen and the scalpel: Effect of diffusion of information on non-clinical variations in surgical treatment.” Medical Care 2008 (in press).